Oral antiviral therapy reduces the risk of hepatocellular carcinoma in persons with chronic hepatitis B infection: combining evidence and common sense Yuanyuan KongHong YouJidong Jia Editorial 23 February 2016 Pages: 239 - 241
Evaluating the living donor: expansion by innovation Chung-Mau Lo Editorial 26 February 2016 Pages: 242 - 244
Acute kidney injury in acute on chronic liver failure Rakhi MaiwallS. K. SarinRichard Moreau Review Article 15 October 2015 Pages: 245 - 257
Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection Sheng-Shun YangJia-Horng Kao Review Article 05 November 2015 Pages: 258 - 266
Non-invasive assessment of portal hypertension and liver fibrosis using contrast-enhanced ultrasonography Hitoshi MaruyamaGamal ShihaMasao Omata Review Article 22 December 2015 Pages: 267 - 276
Advances in therapeutics for chronic hepatitis B Ninghan YangAntonio Bertoletti Review Article 12 September 2015 Pages: 277 - 285
Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back Chengfu Xu Review Article 15 December 2015 Pages: 286 - 293
Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan Chia-Chi WangChih-Lin LinJia-Horng Kao Original Article 23 September 2015 Pages: 294 - 301
Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment Dorota KozielewiczWaldemar HalotaMagdalena Wietlicka-Piszcz Original Article Open access 26 November 2015 Pages: 302 - 309
High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study Tess PetersenKerry TownsendAnita Kohli Original Article Open access 26 November 2015 Pages: 310 - 319
Effects of long-term entecavir treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients Takao WatanabeYoshio TokumotoYoichi Hiasa Original Article 22 July 2015 Pages: 320 - 327
The arterial tumor enhancement pattern on contrast-enhanced computed tomography is associated with primary cancer death after radiofrequency ablation for small hepatocellular carcinoma Ryo ShimizuHideyuki TamaiMasao Ichinose Original Article 03 November 2015 Pages: 328 - 339
High FIB-4 index as an independent risk factor of prevalent chronic kidney disease in patients with nonalcoholic fatty liver disease Huang-Wei XuYung-Chien HsuChun-Liang Lin Original Article 16 December 2015 Pages: 340 - 346
The impact of metabolic syndrome and prevalent liver disease on living donor liver transplantation: a pressing need to expand the pool Waleed Al-hamoudiFaisal AbaalkhailHussien Elsiesy Original Article 04 September 2015 Pages: 347 - 354
Essential components in developing public policy to control viral hepatitis: lessons from Taiwan Jack WallaceMarian PittsDing-Shinn Chen Original Article 04 September 2015 Pages: 355 - 362
Percutaneous recanalization for hepatic vein-type Budd-Chiari syndrome: long-term patency and survival Yan-Feng CuiYu-Fei FuHao Xu Original Article 23 October 2015 Pages: 363 - 369
Low expression of N-myc downstream-regulated gene 2 (NDRG2) correlates with poor prognosis in hepatoblastoma Jan GödekeElke LuxenburgerRoland Kappler Original Article 08 December 2015 Pages: 370 - 376
Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study M. AssemM. ElsabaawyG. El-Azab Original Article 10 December 2015 Pages: 377 - 385
